Your browser doesn't support javascript.
loading
Novel RP-HPLC based assay for selective and sensitive endotoxin quantification.
Bucsella, Blanka; Hoffmann, Anika; Zollinger, Mathieu; Stephan, Fabio; Pattky, Martin; Daumke, Ralph; Heiligtag, Florian J; Frank, Brian; Bassas-Galia, Mònica; Zinn, Manfred; Kalman, Franka.
Affiliation
  • Bucsella B; University of Zürich, Department of Chemistry, Winterthurerstr. 190, Zürich, CH-8057, Switzerland and HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch.
  • Hoffmann A; HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch.
  • Zollinger M; HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch.
  • Stephan F; HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch and Lonza AG, Quality Control Biopharma, Rottenstrasse 6, CH-3930 Visp, Switzerland.
  • Pattky M; HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch and Lonza AG, Quality Control Biopharma, Rottenstrasse 6, CH-3930 Visp, Switzerland.
  • Daumke R; FILTROX AG, Moosmühlestr. 6, CH-9001 St. Gallen, Switzerland.
  • Heiligtag FJ; FILTROX AG, Moosmühlestr. 6, CH-9001 St. Gallen, Switzerland.
  • Frank B; FILTROX AG, Moosmühlestr. 6, CH-9001 St. Gallen, Switzerland.
  • Bassas-Galia M; HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch and FILTROX AG, Moosmühlestr. 6, CH-9001 St. Gallen, Switzerland and Acrostak AG, Stegackerstrasse 14, 8409 Winterthur, Switzerland.
  • Zinn M; HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch.
  • Kalman F; HES-SO Valais (University of Applied Sciences, Sion; Wallis), Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2, Switzerland. franka.kalman@hevs.ch and Acrostak AG, Stegackerstrasse 14, 8409 Winterthur, Switzerland.
Anal Methods ; 12(38): 4621-4634, 2020 10 08.
Article in En | MEDLINE | ID: mdl-32924034
ABSTRACT
The paper presents a novel instrumental analytical endotoxin quantification assay. It uses common analytical laboratory equipment (HPLC-FLD) and allows quantifying endotoxins (ETs) in different matrices from about 109 EU per mL down to about 40 EU per mL (RSE based). Test results are obtained in concentration units (e.g. ng ET per mL), which can then be converted to commonly used endotoxin units (EU per mL) in case of known pyrogenic activity. During endotoxin hydrolysis, the endotoxin specific rare sugar acid KDO is obtained quantitatively. After that, KDO is stoichiometrically reacted with DMB, which results in a highly fluorescent derivative. The mixture is separated using RP-HPLC followed by KDO-DMB quantification with a fluorescence detector. Based on the KDO content, the endotoxin content in the sample is calculated. The developed assay is economic and has a small error. Its applicability was demonstrated in applied research. ETs were quantified in purified bacterial biopolymers, which were produced by Gram-negative bacteria. Results were compared to LAL results obtained for the same samples. A high correlation was found between the results of both methods. Further, the new assay was utilized with high success during the development of novel endotoxin specific depth filters, which allow efficient, economic and sustainable ET removal during DSP. Those examples demonstrate that the new assay has the potential to complement the animal-based biological LAL pyrogenic quantification tests, which are accepted today by the major health authorities worldwide for the release of commercial pharmaceutical products.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endotoxins / Gram-Negative Bacteria Type of study: Diagnostic_studies Limits: Animals Language: En Journal: Anal Methods Year: 2020 Document type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endotoxins / Gram-Negative Bacteria Type of study: Diagnostic_studies Limits: Animals Language: En Journal: Anal Methods Year: 2020 Document type: Article Affiliation country: Switzerland